Literature DB >> 9793274

Acute leukemias after treatment with radioiodine for thyroid cancer.

V Roldán Schilling, P Fernández Abellán, J R Domínguez Escribano, C Rivas González, E Mut Barberá, R Calatayud Cendra.   

Abstract

Leukemia is an uncommon complication of exposure to radioiodine (131I), used in treatment of thyroid cancer, because low doses are now used. We report two cases of acute myelogenous leukemia developed after the treatment of a thyroid carcinoma with a small dose of 131I.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9793274

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


  7 in total

1.  Acute leukemia arising after radioiodine treatment for thyroid cancer.

Authors:  Marine Gilabert; Thomas Prebet
Journal:  Haematologica       Date:  2012-08       Impact factor: 9.941

2.  Successful use of recombinant human thyrotropin in the therapy of pediatric well-differentiated thyroid cancer.

Authors:  M Ralli; P Cohan; K Lee
Journal:  J Endocrinol Invest       Date:  2005-03       Impact factor: 4.256

3.  Myeloid Sarcoma of the Uterine Cervix as Presentation of Acute Myeloid Leukaemia after Treatment with Low-Dose Radioiodine for Thyroid Cancer: A Case Report and Review of the Literature.

Authors:  Anne Sophie Weingertner; Marc Wilt; Ihab Atallah; Cécile Fohrer; Laurent Mauvieux; Jean-François Rodier
Journal:  Case Rep Oncol       Date:  2009-01-17

Review 4.  The spectrum of thyroid diseases in childhood and its evolution during transition to adulthood: natural history, diagnosis, differential diagnosis and management.

Authors:  C A Koch; N J Sarlis
Journal:  J Endocrinol Invest       Date:  2001-10       Impact factor: 5.467

5.  A case of therapy-related acute myeloid leukemia with inv(16)(p13.1q22) after single low-dose iodine-131 treatment for thyroid cancer.

Authors:  Ji Hun Jeong; Jeong Yeal Ahn; Soon Ho Park; Mi Jung Park; Kyung Hee Kim; Jun Shik Hong
Journal:  Korean J Hematol       Date:  2012-09-25

6.  Second malignancies in patients with differentiated thyroid carcinoma treated with low and medium activities of radioactive I-131.

Authors:  Doina Piciu; Claudiu Pestean; Elena Barbus; Maria Iulia Larg; Andra Piciu
Journal:  Clujul Med       Date:  2016-07-28

7.  Acute Myeloid Leukemia after Low-Dose Radioiodine Therapy for Papillary Thyroid Carcinoma.

Authors:  Arwa Alsaud; Shehab Mohamed; Mohamed A Yassin; Amr Ashour; Khaldun Obeidat; Bahjat Azrieh
Journal:  Case Rep Oncol       Date:  2020-03-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.